The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry
Abstract
Rhodanines and related five-membered heterocycles with multiple heteroatoms have recently gained a reputation of being unselective compounds that appear as "frequent hitters" in screening campaigns and therefore have little value in drug discovery. However, this judgment appears to be based mostly on anecdotal evidence. Having identified various rhodanines and related compounds in screening campaigns, we decided to perform a systematic study on their promiscuity. An amount of 163 rhodanines, hydantoins, thiohydantoins, and thiazolidinediones were synthesized and tested against several targets. The compounds were also characterized with respect to aggregation and electrophilic reactivity, and the binding modes of rhodanines and related compounds in published X-ray cocrystal structures were analyzed. The results indicate that the exocyclic, double bonded sulfur atom in rhodanines and thiohydantoins, in addition to other structural features, offers a particularly high density of interaction sites for polar interactions and hydrogen bonds. This causes a promiscuous behavior at concentrations in the "screening range" but should not be regarded as a general knockout criterion that excludes such screening hits from further development. It is suggested that special criteria for target affinity and selectivity are applied to these classes of compounds and that their exceptional and potentially valuable biomolecular binding properties are consequently exploited in a useful way.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, C., Yang, W., & Parr, R. G. (1988) · Physical Review B · doi:10.1103/physrevb.37.785 · Cited by 100,874
Density-functional exchange-energy approximation with correct asymptotic behavior
Becke, A. D. (1988) · Physical Review A · doi:10.1103/physreva.38.3098 · Cited by 53,711
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Unified Approach for Molecular Dynamics and Density-Functional Theory
Car, R., & Parrinello, M. (1985) · Physical Review Letters · doi:10.1103/physrevlett.55.2471 · Cited by 10,754
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
An improved assay for nanomole amounts of inorganic phosphate
Lanzetta, P. A., Alvarez, L. J., Reinach, P. S., & Candia, O. A. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90115-5 · Cited by 2,149
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042
High-throughput assays for promiscuous inhibitors
Feng, B. Y., Shelat, A., Doman, T. N., Guy, R. K., & Shoichet, B. K. (2005) · Nature Chemical Biology · doi:10.1038/nchembio718 · Cited by 336
Rhodanine as a Privileged Scaffold in Drug Discovery
Tomasic, T., & Masic, L. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186200 · Cited by 277
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
Bruno, G., Costantino, L., Curinga, C., Maccari, R., Monforte, F., Nicolò, F., Ottanà, R., & Vigorita, M. G. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00366-2 · Cited by 252
Effect of Detergent on “Promiscuous” Inhibitors
Ryan, A. J., Gray, N. M., Lowe, P. N., & Chung, C.-W. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0340896 · Cited by 231
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Xia, Z., Knaak, C., Ma, J., Beharry, Z. M., McInnes, C., Wang, W., Kraft, A. S., & Smith, C. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800937p · Cited by 194
Steuer, C., Gege, C., Fischl, W., Heinonen, K., Bartenschlager, R. F. W., & Klein, C. D. P. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.015 · Cited by 138
Self-citationSAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase
Powers, J. P., Piper, D. E., Li, Y., Mayorga, V., Anzola, J. V., Chen, J., Jaén, J. C., Lee, G., Liu, J., Peterson, M. G., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050859x · Cited by 131
Ma, L., Xie, C., Ma, Y., Liu, J., Xiang, M., Ye, X., Zheng, H., Chen, Z., Xu, Q., Chen, T., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1011534 · Cited by 102
Bachelier, A., Mayer, R., & Klein, C. D. P. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.021 · Cited by 91
Self-citationVillain-Guillot, P., Gualtiéri, M., Bastide, L., Roquet, F., Martínez, J., Amblard, M., Pugnière, M., & Léonetti, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0703183 · Cited by 80
5-Benzylidene-hydantoins: Synthesis and antiproliferative activity on A549 lung cancer cell line
Zuliani, V., Carmi, C., Rivara, M., Fantini, M., Lodola, A., Vacondio, F., Bordi, F., Plazzi, P. V., Cavazzoni, A., Galetti, M., et al. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.01.035 · Cited by 46
Ooms, F., Wouters, J., Oscari, O., Happaerts, T., Bouchard, G., Carrupt, P., Testa, B., & Lambert, D. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010896y · Cited by 43
Discovery of Low‐Molecular‐Weight Ligands for the AF6 PDZ Domain
Joshi, M., Vargas, C., Boisguérin, P., Diehl, A., Krause, G., Schmieder, P., Moelling, K., Hagen, V., Schade, M., & Oschkinat, H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503965 · Cited by 40
Liu, W., Liu, K., Wood, H. B., McCann, M. E., Doebber, T. W., Chang, C. H., Akiyama, T. E., Einstein, M., Berger, J. P., & Meinke, P. T. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900367w · Cited by 22
Mohler, D. L., Shen, G., & Dotse, A. K. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00440-6 · Cited by 17
Microwave‐Assisted Solvent‐Free Regiospecific Synthesis of 5‐Alkylidene and 5‐Arylidenehydantoins
Lamiri, M., Bougrin, K., Daou, B., Soufiaoui, M., Nicolás, E., & Giralt, E. (2006) · Synthetic Communications · doi:10.1080/00397910600589007 · Cited by 14
Cited by
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00788 · Cited by 588
On Dihydroorotate Dehydrogenases and Their Inhibitors and Uses
Munier-Lehmann, H., Vidalain, P.-O., Tangy, F., & Janin, Y. L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301848w · Cited by 209
Agis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660047 · Cited by 202
Francisco, T. N., Malafaia, D., Melo, L., Silva, A. M. S., & Albuquerque, H. M. T. (2024) · ACS Omega · doi:10.1021/acsomega.3c10417 · Cited by 18
Metadata
- Authors
- Mendgen, T., Steuer, C., & Klein, C. D.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-01-11
- Volume
- 55
- Issue
- 2
- Pages
- 743-753
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1979600197
- Cited by
- 290
- References
- 24
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.